Author: McPadden, Jacob; Warner, Frederick; Young, H. Patrick; Hurley, Nathan C.; Pulk, Rebecca A.; Singh, Avinainder; Durant, Thomas J. S.; Gong, Guannan; Desai, Nihar; Haimovich, Adrian; Taylor, Richard Andrew; Gunel, Murat; Dela Cruz, Charles S.; Farhadian, Shelli F.; Siner, Jonathan; Villanueva, Merceditas; Churchwell, Keith; Hsiao, Allen; Torre, Charles J.; Velazquez, Eric J.; Herbst, Roy S.; Iwasaki, Akiko; Ko, Albert I.; Mortazavi, Bobak J.; Krumholz, Harlan M.; Schulz, Wade L.
Title: Clinical characteristics and outcomes for 7,995 patients with SARS-CoV-2 infection Cord-id: gb3yass0 Document date: 2021_3_31
ID: gb3yass0
Snippet: OBJECTIVE: Severe acute respiratory syndrome virus (SARS-CoV-2) has infected millions of people worldwide. Our goal was to identify risk factors associated with admission and disease severity in patients with SARS-CoV-2. DESIGN: This was an observational, retrospective study based on real-world data for 7,995 patients with SARS-CoV-2 from a clinical data repository. SETTING: Yale New Haven Health (YNHH) is a five-hospital academic health system serving a diverse patient population with community
Document: OBJECTIVE: Severe acute respiratory syndrome virus (SARS-CoV-2) has infected millions of people worldwide. Our goal was to identify risk factors associated with admission and disease severity in patients with SARS-CoV-2. DESIGN: This was an observational, retrospective study based on real-world data for 7,995 patients with SARS-CoV-2 from a clinical data repository. SETTING: Yale New Haven Health (YNHH) is a five-hospital academic health system serving a diverse patient population with community and teaching facilities in both urban and suburban areas. POPULATIONS: The study included adult patients who had SARS-CoV-2 testing at YNHH between March 1 and April 30, 2020. MAIN OUTCOME AND PERFORMANCE MEASURES: Primary outcomes were admission and in-hospital mortality for patients with SARS-CoV-2 infection as determined by RT-PCR testing. We also assessed features associated with the need for respiratory support. RESULTS: Of the 28605 patients tested for SARS-CoV-2, 7995 patients (27.9%) had an infection (median age 52.3 years) and 2154 (26.9%) of these had an associated admission (median age 66.2 years). Of admitted patients, 2152 (99.9%) had a discharge disposition at the end of the study period. Of these, 329 (15.3%) required invasive mechanical ventilation and 305 (14.2%) expired. Increased age and male sex were positively associated with admission and in-hospital mortality (median age 80.7 years), while comorbidities had a much weaker association with the risk of admission or mortality. Black race (OR 1.43, 95%CI 1.14–1.78) and Hispanic ethnicity (OR 1.81, 95%CI 1.50–2.18) were identified as risk factors for admission, but, among discharged patients, age-adjusted in-hospital mortality was not significantly different among racial and ethnic groups. CONCLUSIONS: This observational study identified, among people testing positive for SARS-CoV-2 infection, older age and male sex as the most strongly associated risks for admission and in-hospital mortality in patients with SARS-CoV-2 infection. While minority racial and ethnic groups had increased burden of disease and risk of admission, age-adjusted in-hospital mortality for discharged patients was not significantly different among racial and ethnic groups. Ongoing studies will be needed to continue to evaluate these risks, particularly in the setting of evolving treatment guidelines.
Search related documents:
Co phrase search for related documents- absence presence and active ingredient: 1
- absence presence and acute sars respiratory syndrome virus: 1, 2, 3, 4, 5
- absence presence and adaptive immune response: 1, 2
- absence presence and additional study: 1, 2, 3, 4
- absence presence and admission group: 1
- absence presence and admission infection: 1
- absence presence and admission risk: 1, 2, 3, 4, 5
- academic inpatient and admission infection: 1
- academic inpatient and admission model: 1
- academic inpatient and admission risk: 1
- active ingredient and acute sars respiratory syndrome virus: 1
- active ingredient and additional study: 1
- acute sars respiratory syndrome virus and adaptive immune response: 1, 2, 3
- acute sars respiratory syndrome virus and additional study: 1, 2, 3
- acute sars respiratory syndrome virus and admission group: 1
- acute sars respiratory syndrome virus and admission infection: 1, 2, 3, 4
- acute sars respiratory syndrome virus and admission risk: 1, 2, 3, 4
- adaptive immune response and admission infection: 1
- adaptive immune response and admission risk: 1, 2, 3
Co phrase search for related documents, hyperlinks ordered by date